It seems the content you provided is undefined or missing. Please provide the text you'd like summarized, and I'll be happy to assist!
BAYRY has been in the news recently: Bayer AG is progressing its growth strategy by submitting regulatory filings for darolutamide, finerenone, and elinzanetant, aiming for market introduction by 2025. Additionally, a jury awarded $100 million to plaintiffs who suffered health issues from PCB-containing fluorescent lamps in a school, impacting Bayer’s legal landscape.
📡️ Health Care
In The News
More Signals
Feature in Progress
This section is under development. Check back soon for updates!